The Effect of Aerobic and Resistant Exercise Training in Patients With Non-Alcoholic Steatohepatitis
Non-Alcoholic Steatohepatitis
About this trial
This is an interventional treatment trial for Non-Alcoholic Steatohepatitis focused on measuring fibrosis, exercise, inflammation
Eligibility Criteria
Inclusion Criteria:
- Having been diagnosed with NASH according to the diagnostic criteria determined by the American Gastroenterology Society / Asia-Pacific Working Group,
- No history of hepatic decompensation such as hepatic encephalopathy or abdominal ascites,
- Not being obese according to the criteria of the World Health Organization (Body Mass Index (BMI) <30),
- HbA1c value <6.5%,
- No changes in blood pressure, hyperlipidemia drugs in the last 3 months,
- Absence of any mental disorder or exercise compliance problem that would prevent them from participating in the study.
- It was determined as being voluntary to participate in the study.
Exclusion Criteria:
- A history of liver disease other than NASH, such as acute or chronic viral hepatitis, autoimmune hepatitis,
- Alcohol consumption >30 g/day in men and >20 g/day in women,
- Having regular exercise habits,
- Presence of conditions where exercise is contraindicated, such as unstable ischemia, decompensated heart failure, arrhythmia that increases with exercise and cannot be controlled, severe aortic stenosis, hypertrophic cardiomyopathy,
- Having orthopedic problems that limit lower extremity movements such as previous cerebrovascular disease, neurological diseases that cause cognitive and motor loss such as Alzheimer's and Parkinson's, and endoprosthesis surgery in the last three months, permanent joint contracture,
- Regular use of food supplements,
- It was determined that he did not volunteer to participate in the study.
Sites / Locations
- Hacettepe University, Faculty of Physical Therapy and RehabilitationRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Face-to-Face Training Group
Home-Based Control Group
After completing all assessments, the intervention group will participate in face-to-face exercise training with a physiotherapist for 3 days for 4 months. In the first week, patients will be taught body awareness; parameters of correct loading on the muscle will be explained and the limits of safe exercise will be drawn. At the beginning and end of all exercises, there will be short-term active stretching and relaxation exercises performed by the patient as a warm-up and cool-down period. In the first 4 weeks, it is planned to increase the physical fitness levels of individuals with progressive resistance exercises and to make them suitable for aerobic loading. For each patient, the PRE, resistance will be increased from 60% to 80% for as long as the person can. At the end of the 1st month, the time allocated to resistance exercise training will be reduced and until the end of the 4th month, an increasing intensity aerobic exercise training will be given on the stationary bike.
After the patients assigned to the control group are evaluated by the physiotherapist with field tests and scales for physical functions, the patients will be informed about the importance of lifestyle changes in disease management, gait training will be given to increase their physical activity level and participants will be asked to follow a 45-minute walking program every day within their own means. All patients in the control group will be followed up regularly and their activity levels will be questioned in interim evaluations by asking them to keep a weekly physical activity diary.